Legend Holdings Corporation — Capital/Financing Update 2019

Feb 27, 2019

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [116 x 50] intentionally omitted <==

聯想控股股份有限公司 Legend Holdings Corporation

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 3396)

Connected Transaction Completion of Subscription for Convertible Bonds

Reference is made to the announcements of Legend Holdings Corporation (the “Company”) dated December 21, 2018 (the “Announcement”) and January 16, 2019 in relation to the subscription for the Convertible Bonds of Hospital Corporation of China Limited (弘和仁愛醫療集團有 限公司) (“Hospital Corporation”). Unless otherwise defined, all capitalised terms used in this announcement shall have the same meanings as those defined in the Announcement.

The Board is pleased to announce that all conditions precedent of the Subscription Agreement dated December 21, 2018 (as amended by the amendment agreement to the Subscription Agreement dated January 16, 2019) (the “Amended Subscription Agreement”) have been fulfilled and Closing took place on February 27, 2019. Upon Closing and pursuant to the Amended Subscription Agreement, Leap Wave (as the Subscriber), a wholly-owned subsidiary of the Company, has subscribed for and has been issued by Hospital Corporation the Convertible Bonds in an aggregate principal amount of HK$800,000,000 at an initial Conversion Price of HK$20.00 per Conversion Share.

By order of the Board Legend Holdings Corporation NING Min Executive Director and Joint Company Secretary

Hong Kong, February 27, 2019

As at the date of this announcement, the Executive Directors of the Company are Mr. LIU Chuanzhi, Mr. ZHU Linan, Mr. ZHAO John Huan and Mr. NING Min; the Non-executive Directors are Mr. WU Lebin and Mr. SUO Jishuan; and the Independent Non-executive Directors are Mr. MA Weihua, Mr. ZHANG Xuebing and Ms. HAO Quan.